[Effects and molecular mechanisms of the biological action of weak and extremely weak magnetic fields].
A number of effects of weak combined (static and alternating) magnetic fields with an alternating component of tens and hundreds nT at a collinear static field of 42 microT, which is equivalent to the geomagnetic field, have been found: the activation of fission and regeneration of planarians Dugesia tigrina, the inhibition of the growth of the Ehrlich ascites carcinoma in mice, the stimulation of the production of the tumor necrosis factor by macrophages, a decrease in the protection of chromatin against the action of DNase 1, and the enhancement of protein hydrolysis in systems in vivo and in vitro. The frequency and amplitude ranges for the alternating component of weak combined magnetic fields have been determined at which it affects various biological systems. Thus, the optimal amplitude at a frequency of 4.4 Hz is 100 nT (effective value); at a frequency of 16.5 Hz, the range of effective amplitudes is broader, 150-300 nT; and at a frequency of 1 (0.5) Hz, it is 300 nT. The sum of close frequencies (e.g., 16 and 17 Hz) produces a similar biological effect as the product of the modulating (0.5 Hz) and carrying frequencies (16.5 Hz), which is explained by the ratio A = A0sin omega1t + A0sin omega2t = A0sin(omega1 + omega2)t/2cos(omega1 - omega2)t/2. The efficiency of magnetic signals with pulsations (the sum of close frequencies) is more pronounced than that of sinusoidal frequencies. These data may indicate the presence of several receptors of weak magnetic fields in biological systems and, as a consequence, a higher efficiency of the effect at the simultaneous adjustment to these frequencies by the field. Even with consideration of these facts, the mechanism of the biological action of weak combined magnetic fields remains still poorly understood.
V V
VV
Novikov
V O
VO
Ponomarev
G V
GV
Novikov
V V
VV
Kuvichkin
E V
EV
Iablokova
E E
EE
Fesenko
D016229:Amyloid beta-Peptides / Q000378:metabolism / Q000528:radiation effects; D000803:Angiotensin I / Q000378:metabolism / Q000528:radiation effects; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism / Q000473:pathology*; D004574:Electromagnetic Fields; D006657:Histones / Q000378:metabolism / Q000528:radiation effects; D006868:Hydrolysis; D007328:Insulin / Q000378:metabolism / Q000528:radiation effects; D051379:Mice; D008822:Mice, Transgenic; D009368:Neoplasm Transplantation; D010932:Planarians / Q000502:physiology / Q000528:radiation effects*; D011506:Proteins / Q000378:metabolism / Q000528:radiation effects*
D016229:Amyloid beta-Peptides; D006657:Histones; D007328:Insulin; D011506:Proteins; D000803:Angiotensin I